InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-16.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Seely Lynn, Director. Insider active across 2 companies, notably Blueprint Medicines Corp. In total, 16 filings have been recorded. Split: 1 buy · 5 sells. Total volume traded: €386k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Seely Lynn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
9,589 shares@ US$15.54Common StockSEC:0001327111-26-000006:0
390 shares@ US$14.340.0016% mcap1.9% of flowCommon StockSEC:0001327111-26-000004:0
7,455 shares@ US$23.3957.8% of flowCommon StockSEC:0001327111-26-000002:0
20,000 shares0Common StockSEC:0001327111-26-000001:0
412 shares@ US$16.115.4% of flowCommon StockSEC:0001327111-25-000007:0
40,000 shares0Common StockSEC:0001415889-25-022747:0
391 shares@ US$10.5263.5% of flowCommon StockSEC:0001415889-25-021694:0
3,902 sharesCommon StockSEC:0001104659-25-069390:0
3,902 shares@ US$128.12100.0% of flowCommon StockSEC:0001415889-25-018082:0
175,000 shares@ US$0.6068100.0% of flowCommon StockSEC:0001415889-25-008509:0
Canonical exit: 12 Jun 2025 (T+90)
337,500 shares0Common StockSEC:0001415889-25-005768:0
2,242 shares0Common StockSEC:0001415889-24-016983:0
200,000 shares0Common StockSEC:0001209191-24-003269:0
2,600 shares0Common StockSEC:0001415889-23-010262:0
2,600 shares0Common StockSEC:0001415889-22-007128:0
2,250 shares0Common StockSEC:0001179110-21-006416:0
16 of 16 declarations
About Seely Lynn
Seely Lynn is Administrateur at Lyell Immunopharma, Inc. and a director at Blueprint Medicines Corp. He has 14 filings in total. In the 14 most recent sampled filings, buys amount to EUR 97820 and sells to EUR 155951, over the period from 2021-06-04 to 2026-02-12, with the modal transaction nature listed as Attribution.
